Colombia Violence Claims at Least 52 Lives Raising Security and Economic Concerns ADP Private Payrolls Rise 109000 in April Exceeding Expectations Fed Rate Cut Hopes Diminish Michael Saylor Says Tokenization Could Create Free Market for Yield and Credit Should You Take Social Security Early and Switch to Survivor Benefits Later A Case Study at 62 Technical Analysis Points to Bullish IntermediateTerm Outlook for Markets Top Doctors Warn Social Media as Harmful as Smoking for Youth Potential Regulatory and Revenue Risks for Tech Giants LB Foster Q1 2026 Earnings Strong EPS Surprise Despite Revenue Uncertainty RACE Q1 2026 Earnings EPS Beat Drives Modest Stock Gains Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development Celanese Corporation Q1 2026 Earnings EPS Miss Amid Cost Headwinds Stock Edges Lower CENTA Q1 2026 Earnings EPS Surpasses Estimates by 154 HSY Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Spire Global Inc SPIR Surges Over 7 Breaking Past Key Resistance Levels Phoenix New Media FENG Holds Steady at 168 as Consolidation Continues Near Support Ryan Specialty Holdings RYAN Edges Higher Approaching Key Resistance Level BMGL Shares Edge Higher Amid Positive Price Action Jazz Pharmaceuticals JAZZ Dips Slightly Key Support and Resistance Levels in Focus Coastal Erosion Threatens UK Infrastructure Assets Roads Homes and Railways at Risk NEXN Q3 2025 Earnings EPS Surges Past Estimates Stock Rises 122 Solo Brands Inc SBDS Slides Modestly Amid Broader Market Pressure Seacoast Banking Corporation of Florida SBCF Q1 2026 Earnings Solid EPS Beat Signals Operational Resilience Expedia Group Q1 2026 Earnings EPS Surges Past Estimates as Travel Demand Strengthens KRMN Q1 2026 Earnings EPS Misses Estimates Stock Declines Sharply AMT Q1 2026 Earnings Strong EPS Beat Driven by Solid Operational Performance AVNS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency EIG Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher ORMP Q4 2025 Earnings Surprise Profit Beats Zero Estimate as Biotech Advances Pipeline